戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  However, due to oxidation reaction in vivo, no significant difference between (64)Cu(I) and (64)Cu(I
2                                   There were no significant differences between ACHD and non-ACHD pat
3  and 171+/-87 after adenosine (P<0.07), with no significant differences between adenosine and mental
4  compared with control eyes (P = .008), with no significant difference between advanced and intermedi
5                                    There was no significant difference between all diets on inflammat
6  were observed in mixed batch, and there was no significant difference between aluminum and iron elec
7                                   There were no significant differences between antidepressants and c
8 ts, low- to very-low-quality RCT data showed no significant difference between any biologic therapy a
9                                    There was no significant difference between any of the models or b
10 le strength and in vitro cytotoxicity showed no significant difference between AuNP-infused and untre
11                                  We detected no significant differences between BDII patients and con
12  lie in a narrow range similar to bone, with no significant difference between benign and malignant.
13                         PET using BKC showed no significant difference between bioluminescence and en
14 rm estrogen deficiency (34 weeks), there was no significant difference between bone cells in healthy
15                                  We detected no significant differences between bortezomib- and place
16 CP1 to respiratory complex components showed no significant differences between brown and brite adipo
17 ed Cox regression analysis, there were still no significant differences between BRS and DES (hazard r
18                                  We observed no significant differences between cases and controls in
19 (2 of 14 subjects; 14.3%) treatment arms and no significant difference between change in Montgomery-A
20                                              No significant difference between changes in 12 months a
21                                    There was no significant difference between ciclosporin and inflix
22                                     We found no significant difference between clindamycin and TMP-SM
23                                   There were no significant differences between closed-loop and contr
24                                    There was no significant difference between control (58 +/- 2%CVCm
25 ion fraction and conventional metrics showed no significant differences between control and cardiomyo
26 umetric and DTI analysis measurements showed no significant differences between control and Hdc KO mi
27 al components analysis of the datasets found no significant differences between conventionally- and o
28     Analysis of journal impact factor showed no significant difference between correct and incorrect
29 p visits during that interval, and there was no significant difference between counseling groups.
30                                    There was no significant difference between CPAP and MADs in their
31                          Likewise, there was no significant difference between CSF flow measured with
32                                              No significant differences between DFT versus no-DFT coh
33                                   There were no significant differences between diets for HDL cholest
34                                    There was no significant difference between DM and DBT with regard
35                                   There were no significant differences between donors and nondonors
36                                    There was no significant difference between doses for safety and i
37 ences between these groups and controls, but no significant differences between each other.
38                  The primary analysis showed no significant difference between eculizumab and placebo
39 nts with postinfectious hydrocephalus showed no significant difference between endoscopic ETV-CPC and
40                                   There were no significant differences between European regions in t
41                                    There was no significant difference between exiting and nonexiting
42 ts with an elevated d-dimer level, there was no significant difference between extended-duration betr
43        The LC ranged from 0.43 to 2.53, with no significant difference between fasting and clamping.
44  within 8 to 30 days (n = 27176), there were no significant differences between follow-up at 2 months
45                                    There was no significant difference between good adherence, poor a
46          Preoperative PNS-O and PNS-P showed no significant difference between groups (P = 0.267).
47 was 2.7 +/- 2.8 mm (95% CI, 2.2 to 3.4) with no significant difference between groups (P = 0.40).
48 was 8.5 +/- 3.8 mm (95% CI, 7.6 to 9.3) with no significant difference between groups (P = 0.73).
49 f 81 patients had cognitive impairment, with no significant difference between groups (treatment effe
50 placebo group had cognitive impairment, with no significant difference between groups (treatment effe
51 AMR and Banff scores at 1 and 6 months, with no significant difference between groups but with a tren
52                                    There was no significant difference between groups for any seconda
53                        At 52 weeks, we noted no significant difference between groups for disease pro
54                                    There was no significant difference between groups I and III or be
55  In an intention-to-treat analysis, we found no significant difference between groups in 6-month cumu
56                                    There was no significant difference between groups in AR dimension
57  for the primary endpoint, because there was no significant difference between groups in mean daily b
58  for the primary endpoint, because there was no significant difference between groups in mean daily b
59                                    There was no significant difference between groups in pain-related
60                                    There was no significant difference between groups in quality-adju
61 t (IDR 1.39 [95% CI 1.07-1.79]) and we noted no significant difference between groups in readmission
62 edoke-McMaster, and stroke severity revealed no significant difference between groups in the primary
63                                    There was no significant difference between groups in the primary
64                                    There was no significant difference between groups in the primary
65 , fitness, physical activity, and diet, with no significant difference between groups.
66                Adverse events were rare with no significant difference between groups.
67  means of 17.6 for GPT and 16.5 for CM, with no significant difference between groups.
68 ticipants in the clinic referral group, with no significant differences between groups (p=0.668 for c
69 aker/defibrillator implantation demonstrated no significant differences between groups after adjustme
70                                   There were no significant differences between groups for hemoglobin
71 rocessed by sHLD, dHLD, or HLD/ETO, we found no significant differences between groups for MDRO or ba
72                     At age 18 mo, there were no significant differences between groups in any scores.
73                                   There were no significant differences between groups in baseline ch
74  95% CI, 0.51-0.67; I2 = 0%), but there were no significant differences between groups in duration of
75 nt of much or very much in CGI-I score, with no significant differences between groups in either clin
76                                   There were no significant differences between groups in FACT-G scor
77                                   There were no significant differences between groups in hospitaliza
78  versus recurrent disease groups: There were no significant differences between groups in incidence o
79                                   There were no significant differences between groups in MACE relate
80                                   There were no significant differences between groups in nasogastric
81                                   There were no significant differences between groups in patients' g
82                                              No significant differences between groups in rates of ma
83                                   There were no significant differences between groups in serotype-sp
84                                   There were no significant differences between groups in stridor or
85 % CI, 0.20 to 0.79; P=0.009), but there were no significant differences between groups in the other s
86                         Likewise, there were no significant differences between groups in the seconda
87                                   There were no significant differences between groups in time taken
88                                   There were no significant differences between groups in time to ext
89                                              No significant differences between groups were observed
90 fore surgery, steep and flat keratometry had no significant differences between groups, and at last f
91 nts showed good periodontal parameters, with no significant differences between groups.
92 les compared with the all-IPV schedule, with no significant differences between groups.
93 outh experienced improvement on the CIS with no significant differences between groups.
94           Liver BCMO1 activity was low, with no significant differences between groups.
95 e at 90 days) and adverse events, there were no significant differences between groups.
96 TATION: For the primary outcomes, there were no significant differences between groups.
97 e of the pyrolysates was highly variable and no significant difference between HA and FA was found fo
98                 Multivariate analysis showed no significant difference between Haplo-HCT and MSD-HCT
99 ss all animals and activation sequences with no significant difference between homogeneous and inhomo
100 with central hypersomnolence disorders, with no significant differences between hypocretin-deficient
101                                   There were no significant differences between Imm-RDI and Inc-AA gr
102               In adjusted models, there were no significant differences between induction groups for
103                                  We observed no significant difference between intermittent and conti
104                                              No significant differences between intervention groups a
105                                    There was no significant difference between IOL groups in Rasch-ad
106 microwave pasteurised juice at day 0 however no significant differences between juices were observed
107                                    There was no significant difference between lanicemine and placebo
108 ) of subjects with HCV genotype 1 infection (no significant difference between ledipasvir/sofosbuvir
109 k densities in the dorsotemporal area showed no significant difference between left and right eyes fo
110                                              No significant differences between letrozole and placebo
111                                              No significant difference between line scans/correspondi
112 , multivariable regression analysis revealed no significant differences between MACH and GBAE implant
113 as bone fill after 6 months of healing, with no significant difference between materials.
114                           However, there was no significant difference between mean early PPG and lat
115                                   There were no significant differences between men and women in thei
116 s vs individuals with epsilon3/epsilon4, but no significant differences between men and women with ep
117 nce risk for CHD in offspring was 4.8%, with no significant differences between men and women with TO
118                               There was also no significant difference between MI size3-slices and MI
119                                We also found no significant differences between migration among coast
120                           Results There were no significant differences between morning and afternoon
121               We hypothesized that there was no significant difference between MSA as measured by DAS
122               For steatosis degree there was no significant difference between MSG-obesity group and
123                                     There is no significant difference between MT4 and MSP for detect
124 uniformly labeled E. coli peptides indicated no significant differences between observed and simulate
125 OR], 0.48; 95% CI, 0.25-0.92), but there was no significant difference between omalizumab and ICS boo
126 d to have a unique mutational signature with no significant differences between parental alleles, sug
127                  Secondary analyses revealed no significant difference between patient groups in leng
128                                   There were no significant differences between patients treated with
129                                   There were no significant differences between patients with IBD in
130                  In both cohorts, there were no significant differences between patients with stage I
131  scores during treatment; however, there was no significant difference between placebo and riluzole o
132 t differences in clinical outcomes, and thus no significant differences between polypill and comparat
133 s and 1, 2, and 4 weeks after surgery showed no significant differences between PPC and CCC in cornea
134 ing over $10,000 in income during leave with no significant difference between procedural and nonproc
135                                   There were no significant differences between progression of vascul
136                       The null hypothesis of no significant difference between pulse sequences was as
137 respectively, increased ICAD prevalence with no significant differences between races.
138 The analysis of variance (alpha=0.05) showed no significant differences between rate constants of the
139                                   There were no significant differences between SCL and RGPL wearing
140 descence throughout the year was noted, with no significant differences between seasons (P = 0.699).
141                  All changes were mild, with no significant differences between severe and nonsevere
142                 Although globally there were no significant differences between sexes in the proporti
143                                    There was no significant difference between SI values measured in
144                                     We noted no significant differences between statin users and non-
145 lthough task performance improved over days, no significant difference between stimulation protocols
146                                   There were no significant differences between studies with low vers
147                                    There was no significant difference between study arms in 52-week
148                                    There was no significant difference between study groups in 60-day
149                                   There were no significant differences between study groups in resid
150                                              No significant difference between subfoveal center point
151                                    There was no significant difference between summed PI-RADS scores
152                                    There are no significant differences between superior and temporal
153 d survival compared with surgery alone, with no significant difference between surgery-based multimod
154 tures involving the surgical neck, there was no significant difference between surgical treatment com
155                         In the NOTION trial, no significant difference between TAVR and SAVR was foun
156                                   There were no significant differences between TAVR and SAVR in any
157                                              No significant difference between TBMES and osteonecrosi
158 ath (4.4% vs. 0.6%, P=0.001), but there were no significant differences between tenofovir-based ART a
159                                    There was no significant difference between the 2 active groups.
160                               There was also no significant difference between the 2 closure methods
161 onths and 1 year after discharge also showed no significant difference between the 2 groups of patien
162                                    There was no significant difference between the 2 groups with rega
163                           However, there was no significant difference between the 2 intervention arm
164                                    There was no significant difference between the 2 measures of PHE
165        Statistical analysis showed there was no significant difference between the ability of the thr
166                                    There was no significant difference between the Absorb group and t
167                                    There was no significant difference between the area under the cur
168      Experimental data showed that there was no significant difference between the benchtop protocol
169 llel analysis of 30 cancer patients, to find no significant difference between the capture efficiency
170 ls (39 eyes) returning after LASIK, we found no significant difference between the clinically measure
171                                    There was no significant difference between the cohorts in the per
172 experienced no discontinuities, and we noted no significant difference between the CTO and control gr
173 improvement in ACQ score; however, there was no significant difference between the CYT003 and placebo
174 ess, and the results revealed that there was no significant difference between the data sets obtained
175                                     There is no significant difference between the effect of topical
176    In intention-to-treat analysis, there was no significant difference between the elafibranor and pl
177                           Moreover, we found no significant difference between the ES for N170 and N2
178                                    There was no significant difference between the ETV-CPC group and
179 70) after TIPS placement (all P < .05), with no significant difference between the first and second p
180 ngth for group 1 and 7.09% for group 2, with no significant difference between the groups (P = .09).
181                                    There was no significant difference between the groups for Unified
182                                    There was no significant difference between the groups in terms of
183                                    There was no significant difference between the groups in the mean
184                                    There was no significant difference between the groups in the rela
185                                    There was no significant difference between the groups in their tr
186                                    There was no significant difference between the groups with respec
187                                    There was no significant difference between the IB or TB conjuncti
188                                    There was no significant difference between the levosimendan group
189 male control group (P = .040), and there was no significant difference between the male MTBI group an
190 is (Fisher's exact test) indicated there was no significant difference between the methods at the 99%
191            Calibration analysis demonstrated no significant difference between the model (predicted v
192 ular involvement when compared with SJS, but no significant difference between the number of moderate
193                                    There was no significant difference between the numbers of IFTA or
194                                    There was no significant difference between the observed and predi
195                                              No significant difference between the outcomes of the tw
196                                    There was no significant difference between the particle sizes of
197 In an intention-to-treat analysis, there was no significant difference between the pessary group (465
198  respectively; P = 0.042), whereas there was no significant difference between the placebo trained an
199                                    There was no significant difference between the progesterone group
200                                     We found no significant difference between the regions in the pos
201                        Analysis demonstrated no significant difference between the SGS group and the
202 darterectomy versus Stenting Trial, we found no significant difference between the stenting group and
203                                    There was no significant difference between the study groups in th
204                                    There was no significant difference between the study groups with
205        In a time-to-event analysis, we found no significant difference between the supplemental-oxyge
206                               There was also no significant difference between the SUVmax of all DTCs
207                         Two-way ANOVA showed no significant difference between the traditional plate
208                                    There was no significant difference between the treatment groups i
209                           However, there was no significant difference between the trial groups eithe
210                                    There was no significant difference between the two genotype group
211                                    There was no significant difference between the two groups for ven
212                                    There was no significant difference between the two groups in OI a
213 ion whereas the duration of vigilance showed no significant difference between the two habitats.
214 aroxysmal atrial fibrillation, and there was no significant difference between the two methods with r
215  (p<0.0001 for both groups vs placebo), with no significant difference between the two seladelpar gro
216 n D. ambigua, but by 20 degrees C, there was no significant difference between the two species, and a
217                                    There was no significant difference between the two study groups i
218                                   There were no significant differences between the 2 experimental gr
219 ts at the time of stent thrombosis, we found no significant differences between the 2 stent groups fo
220         In comparisons of outcomes, we found no significant differences between the 3-year vs 5-year
221  characteristic curve, was 0.87 to 0.89 with no significant differences between the 7 more sensitive
222                      In addition, there were no significant differences between the acetylcysteine gr
223                                   There were no significant differences between the active and placeb
224                                   There were no significant differences between the agriculturalist a
225                                   There were no significant differences between the colchicine and pl
226                                   There were no significant differences between the early group and t
227 he drought-tolerant PFT; however, there were no significant differences between the early- and late-s
228                                   There were no significant differences between the ganciclovir and p
229  -0.59], p=0.015), but the GAF scores showed no significant differences between the groups (61.2 [SD
230                                   There were no significant differences between the groups (hazard ra
231 of 18 complications occurred, but there were no significant differences between the groups (P=0.21).
232 inclusion in the 5-year analysis, there were no significant differences between the groups in clinica
233                                   There were no significant differences between the groups in end-exe
234                                   There were no significant differences between the groups in the len
235                                   There were no significant differences between the groups in the sec
236                          However, there were no significant differences between the groups on cortiso
237                                   There were no significant differences between the groups regarding
238 l thromboplastin time showed variability but no significant differences between the groups.
239 re improved during follow-up, but there were no significant differences between the groups.
240                          However, there were no significant differences between the intervention arms
241  patient safety climate), whereas there were no significant differences between the intervention grou
242  brief motivational intervention, there were no significant differences between the intervention grou
243                          For DBP, there were no significant differences between the intervention grou
244                                   There were no significant differences between the Kd values of chit
245                                   There were no significant differences between the levosimendan grou
246              A two-sample t test resulted in no significant differences between the lung injury and h
247                                   There were no significant differences between the parenteral group
248                                   There were no significant differences between the randomisation gro
249                        Paired t tests showed no significant differences between the reference standar
250                                   There were no significant differences between the respective serum
251                                              No significant differences between the RIPC group and th
252                                   There were no significant differences between the statin users and
253                                   There were no significant differences between the strawberry and co
254 luded up to 5 years of follow-up, there were no significant differences between the study groups in t
255  Qualitative image quality analyses revealed no significant differences between the three CT angiogra
256 ing high-risk genotypes, were detected, with no significant differences between the treatment groups
257                              There were also no significant differences between the treatment groups
258                                              No significant differences between the treatment groups
259                                   There were no significant differences between the two groups in any
260                                   There were no significant differences between the two groups in ter
261                                   There were no significant differences between the two groups in the
262                                   There were no significant differences between the two groups in the
263                                   There were no significant differences between the two interventions
264 h month - baseline) of those scores revealed no significant differences between the two IT groups, TA
265  over a median of 3 years of follow-up, with no significant differences between the two treatment gro
266                                   There were no significant differences between the two treatment gro
267 's index) and abundance suggested there were no significant differences between the two types of maiz
268          For arterial procedures, there were no significant differences between the uninterrupted and
269                                   There were no significant differences between the unique variant se
270 ther grade 3 or 4 toxicities were rare, with no significant differences between the VTD and VCD arms.
271 electron microscopy revealed that there were no significant differences between the wild-type and mut
272 -specific antibodies as soon as day 12, with no significant difference between them but with a trend
273                                    There was no significant difference between these results and the
274 /mL plasma for one month and since there was no significant difference between these two, the less co
275 ent ICH and ischaemic stroke after ICH found no significant differences between these risks.
276 ween those assigned PrEP versus placebo, and no significant difference between those assigned PrEP an
277    Among patients undergoing CABG, there was no significant difference between those receiving single
278 analysis with the log-rank test demonstrated no significant differences between those omitting vs rec
279       In patients undergoing PCI, there were no significant differences between those receiving drug-
280 ary care at 4 VA medical centers, there were no significant differences between those with time-limit
281                                    There was no significant difference between treatment (N = 408) or
282                           Overall, there was no significant difference between treatment arms in the
283                                    There was no significant difference between treatment groups for t
284                                  We detected no significant difference between treatment groups for:
285 nths with C25, and 5.3 months with D75, with no significant differences between treatment arms.
286                 In persistent AF, there were no significant differences between treatment groups for
287                              There were also no significant differences between treatment groups for
288           Similarly, at 16 weeks, there were no significant differences between treatment groups in c
289 covering and HR for recovering also revealed no significant differences between treatment groups in e
290 iodontal clinical parameters and OHRQL, with no significant differences between treatment groups.
291                                    There was no significant difference between treatments for any par
292  surface potentials of -42.4 to -46.1mV with no significant difference between treatments, suggesting
293 solids content decreased during storage with no significant difference between treatments.
294 vastatin group had virological failure, with no significant difference between treatments.
295                        In the PPAA there was no significant difference between two hemispheres in eac
296                                    There was no significant difference between UC and CD.
297               However, direct evidence found no significant difference between vision screening in ol
298                                   There were no significant differences between vitamin D and placebo
299             In all but 1 of our comparisons, no significant difference between wildtype and heterozyg
300     However, overall clinical outcome showed no significant difference between women and men after 1

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top